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Ovarian surgery during pregnancyIn this issue, Koo and colleagues authored an interesting
article entitled “An 11-year experience with ovarian surgery
during pregnancy”.1 They investigated the characteristics and
outcomes of pregnant women who underwent surgical inter-
vention for ovarian neoplasm and found that either conven-
tional laparotomy or laparoscopy approach could be
successfully used in the management of ovarian tumor during
pregnancy without adverse events.1 We acknowledge the
probity of this publication.
Ovarian neoplasms, presenting as either benign or
malignant tumors, now can easily be identified and likely
more often detected because of the widespread use of
ultrasound earlier in pregnancy. The incidence rate of ovar-
ian tumors in pregnancy is around 0.05% of all deliveries.2
Although the incidence rate is still low, ovarian tumors
remain a challenge for clinical physicians. This is in part,
because proper medical management of these tumors by
necessity takes into consideration both the technical diffi-
culty caused by enlargement of the uterus, and the risk of
fetal loss. Caring for these pregnant patients should always
involve multidisciplinary teamwork with the aim of opti-
mizing outcomes for both the mother and the fetus.3 Before
surgery, it is important to obtain an obstetrics consultation to
discuss key aspects of maternal physiology and anatomy.4
Besides the obstetrics specialty, we can also obtain val-
uable contributions from anesthesiology, pediatrics, and even
a surgical consultation to protect most efficaciously the
safety of the mother and fetus.3
In the Koo et al study,1 the most common type of ovarian
neoplasm during pregnancy was mature teratoma, which was
consistent with previous studies,3 although some studies have
shown variation, including benign cystadenoma (41.9%).4
However, all studies have shown that primary ovarian malig-
nancies are extremely rare.5,6 Koo et al1 reminded us of the
possibility of secondary ovarian tumors, because they found
that both ovarian malignancies were secondary to metastasis
from other organs, especially gastrointestinal tract malignancy.
Since the development of high-resolution imaging tools,
particularly ultrasound and magnetic resonance imaging, such
tools have been reported to have a clear ability to distinguish
benign from malignant neoplasms of the adnexa. This accurate
diagnosis is important because it helps us to reach informed
decisions about the relative necessity of a surgical approach
for ovarian tumors during pregnancy.7 If the tumor diameter1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.04.009is >10 cm, or shows atypical appearance or complex content
within the tumor, the risk of malignancy is significantly ele-
vated (8.77% vs. 0.85%; odds ratio 11.2, 95%, confidence
interval ¼ 1.3e97.9).8 In fact, Wang and colleagues in 1997
found that the size of a malignant tumor was significantly
larger than that of a benign tumor (12.8 vs. 8.5 cm, p < 0.001)
and the tumor size of malignant ovarian tumors was >10 cm in
nearly all patients ( p ¼ 0.03). By contrast, carbohydrate
antigen 125 serum level and gray-scale scoring (>9) cannot
distinguish benign from malignant tumors.9 In the Koo et al
study, the authors also emphasized the importance of tumor
size, and suggested that surgical intervention can be consid-
ered when the tumor is >10 cm, whereas surgery can be
delayed for those <5 cm.1
The principles relating to ovarian surgery can follow
guidelines originally designed for other nonobstetric surgery.
For example, American College of Obstetricians and Gyne-
cologists committee recommendations suggest that non-
emergency surgery should be undertaken in the second
trimester, because the possibility of uterine contraction and
rate of spontaneous abortion are both lower.4 One report has
shown that the rates of preterm contraction and miscarriage
are about 5.8% and 2.9%, respectively, if adnexal surgery is
performed in this trimester.10 The majority of cases (74%) in
the Koo et al study were also managed in the second
trimester.1
In addition, most ovarian neoplasms are asymptomatic.11,12
Therefore, elective surgery can, if possible, be delayed until or
after delivery. By contrast, based on the previous study by
Wang et al,12 ovarian surgery can be performed as early as
gestational week 8.
Third, if surgery is warranted due to suspicion of malig-
nancy, risk for torsion, or clinical symptoms, electronic fetal
heart rate and uterine contraction should be monitored before,
during, and after surgery to evaluate fetal wellbeing and the
uterine contractions.
Fourth, with increasing numbers of successful laparoscopic
surgeries reported during pregnancy, laparoscopy has become
an acceptable alternative to standard laparotomy in any tri-
mester.13 Laparoscopic entry techniques, such as use of the
Veress needle, Hasson trocar, or optical trocar, all can be
safely performed during pregnancy. Postoperative hospital stay
after laparoscopic surgery is significantly shorter than for
those receiving laparotomy; such abbreviated stays may alsohinese Medical Association. All rights reserved.
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study,1 20% of the patients underwent laparoscopic surgery,
and all of them were performed electively using general
anesthesia. However, the article failed to provide further
information such as blood loss, operative time, hospital stay,
and visual analog pain scores. Therefore, the feasibility of
laparoscopic surgery for pregnant women with ovarian tumor
needs considerably stronger evidence.
The majority of ovarian neoplasms that occur during
pregnancy are usually benign, and malignancy is rare. How-
ever, laparotomy or laparoscopy for scheduled or emergency
surgery is still sometimes required, although it may increase
the risk of preterm uterine contraction or fetal wastage. Con-
sequently, preconception counseling and sonographic evalua-
tion might be a better alternative for many patients, in an effort
to decrease pathological ovarian tumors during pregnancy. For
example, removal of mature teratoma before conception might
significantly diminish the incidence of ovarian surgery during
pregnancy.
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